Cargando…
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
BACKGROUND: Grass pollen is one of the most important sources of respiratory allergies worldwide. OBJECTIVE: This study describes the development of a grass pollen allergy vaccine based on recombinant hypoallergenic derivatives of the major timothy grass pollen allergens Phl p 1, Phl p 2, Phl p 5, a...
Autores principales: | Focke-Tejkl, Margarete, Weber, Milena, Niespodziana, Katarzyna, Neubauer, Angela, Huber, Hans, Henning, Rainer, Stegfellner, Gottfried, Maderegger, Bernhard, Hauer, Martina, Stolz, Frank, Niederberger, Verena, Marth, Katharina, Eckl-Dorna, Julia, Weiss, Richard, Thalhamer, Josef, Blatt, Katharina, Valent, Peter, Valenta, Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418753/ https://www.ncbi.nlm.nih.gov/pubmed/25441634 http://dx.doi.org/10.1016/j.jaci.2014.09.012 |
Ejemplares similares
-
Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitis
por: Wu, Yu-Chang B., et al.
Publicado: (2014) -
Intradermal grass pollen immunotherapy increases T(H)2 and IgE responses and worsens respiratory allergic symptoms
por: Slovick, Anna, et al.
Publicado: (2017) -
Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
por: Chen, Jiun-Bo, et al.
Publicado: (2017) -
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014) -
Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD
por: Zhu, Jie, et al.
Publicado: (2020)